What SSPC does

SSPC, formally 'Research Ireland Centre for Pharmaceuticals', is a publicly funded pharmaceutical research centre hosted at the Bernal Institute, University of Limerick, Ireland. Founded in 2007 by Professor Emeritus Kieran Hodnett under the original name Synthesis and Solid State Pharmaceutical Centre, it received cumulative Research Ireland grants of €6M (2007), €40M (2013), and €61M (2019) across three funding cycles and expanded in its current iteration to span the entire drug production chain across six research themes: Molecule (asymmetric synthesis), Materials (crystalline and amorphous solid forms), Medicines (formulation), Manufacturing (continuous manufacturing and flow chemistry), Modelling (computational and CFD), and Bio Capabilities (biologics, mRNA, ATMPs). Day-to-day leadership sits with Director Professor Damien Thompson.

Operationally, SSPC functions as a multi-university research collaboration (University of Limerick, University College Dublin, Trinity College Dublin, Dublin City University, and Maynooth University, plus NIBRT) delivering collaborative R&D, an internal PhD training programme, industry placements, and process-development consulting to pharmaceutical and biopharmaceutical firms. Named industry partners include Pfizer, Johnson & Johnson Innovative Medicine, Eli Lilly, AbbVie, Regeneron, Sanofi, MSD, Janssen, Alkermes and Clarochem Ireland, with 50+ active industry partners and 54 funded industry projects since 2019. SSPC's output has been 604 peer-reviewed publications since 2013 (with co-authors across 48 countries) and a 63% graduate-to-industry employment rate; commercial translation has produced spinouts such as ArrayPatch Ltd (Feb 2026 €3M seed).

Revenue mechanics are non-commercial: SSPC's primary income is multi-year Research Ireland grant funding supplemented by industry partner contributions, EU and government programme funding, and CPD delivery — the centre does not sell products and pricing is not publicly disclosed. Distribution of outputs happens via direct enterprise partnerships, peer-reviewed publications, an annual symposium, a webinar series, and an active social/digital presence. The organisation is not privately held, has no disclosed traditional equity investors, and acts as Ireland's national translational pharma research hub rather than a commercial vendor.

Name

SSPC

Legal name

SSPC, Research Ireland Centre for Pharmaceuticals

Website

https://sspc.ie

Company type

Private

Founded year

2007

Operating status

Operating

Headcount range

51–100 employees

Short description

SSPC is Ireland's national publicly funded pharmaceutical research centre, hosted at the University of Limerick across five partner universities. It delivers collaborative R&D, an industry-linked PhD training programme, and process development to over 50 pharma and biopharma industry partners across small molecules, biologics, ATMPs, and continuous manufacturing.

Ownership category

akta.pro rank

Headquarters

HQ city

Dublin

HQ country

Ireland

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Operations, Infrastructure

Revenue model

1. Research Funding: SSPC receives primary funding from Research Ireland (formerly Science Foundation Ireland) as a designated Research Centre for Pharmaceuticals. Additional funding comes from industry partners, EU programmes, and government departments.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels9 records

Core offering

SSPC is a national research centre that delivers collaborative pharmaceutical R&D from molecule to medicine. It partners with global drug manufacturers and academic institutions to develop applied technologies in flow chemistry, continuous manufacturing, asymmetric synthesis, pharmaceutical crystallization, amorphous solid forms, computational modelling, biologics, and mRNA therapeutics. Its research outputs include peer-reviewed publications, trained PhD scientists (with a 63% industry transition rate), and industry-grade process development support.

Product overview

SSPC (Science Foundation Ireland Research Ireland Centre for Pharmaceuticals) is a research center, not a product company. It operates as a hub of Irish research expertise developing innovative technologies to address challenges facing the pharmaceutical and biopharmaceutical industry. SSPC's research spans the pharmaceutical production chain from molecule to medicine across six interconnected research themes: Molecule (synthesis and molecular design), Materials (crystalline materials), Medicines (formulation), Manufacturing (continuous processing and flow chemistry), Modelling (computational prediction), and Bio Capabilities (biologics and ATMPs). The center collaborates with industry partners and academic institutions, with software products like Dynochem and Scale-up Suite emerging from spin-out companies rather than being direct SSPC offerings.

Differentiator

Problem solved

Functional benefit

Products and services

• SSPC Research Programme - Molecule Collaborative research programme focused on developing new methodologies for the asymmetric synthesis of APIs, molecules, and methods for automated and in-flow generation of targeted drug hybrids and new therapeutic agents; targeted at pharmaceutical industry partners.
• SSPC Research Programme - Materials Applied and fundamental research on pharmaceutical solid forms including single-component crystalline materials (SCCMs) and multi-component crystalline materials (MCCMs), aimed at controlling solid-state forms and particle properties for improved orally delivered drug products; offered to pharmaceutical companies and academic collaborators.
• SSPC Research Programme - Medicines Research programme optimising the development, production, and use of safe, effective medicines, with emphasis on poorly soluble drugs, personalised medicines, age-appropriate formulations, and rational formulation design; targeted at the pharmaceutical industry.
• SSPC Research Programme - Manufacturing Applied research enabling disruptive change in drug substance and drug product manufacture through continuous manufacturing, flow chemistry, and end-to-end manufacturing methodologies; offered to pharmaceutical companies seeking innovative manufacturing solutions.
• SSPC Research Programme - Modelling Research developing in silico techniques to design and predict behaviour, reduce trial-and-error experimentation, and build transformative physical models for drug manufacture — including computational fluid dynamics, population balance models, and machine learning approaches for crystallisation and bioreactor scale-up; offered to pharmaceutical industry partners.
• SSPC Research Programme - Bio Capabilities Research capabilities covering biologics, biopharmaceuticals, and advanced therapy medicinal products (ATMPs), including mRNA stability research and biopharmaceutical training programmes in collaboration with NIBRT; targeted at biopharmaceutical companies.
• SSPC Industry Collaboration Programme Collaborative industry research engagement model in which SSPC delivers tailored applied research to over 50 industry partners — including Pfizer, Johnson & Johnson, Eli Lilly, Regeneron, AbbVie, Sanofi, MSD, Janssen, Alkermes, and Clarochem Ireland — covering process development, manufacturing science & technology, and innovative formulations.
• SSPC PhD Training Programme and Industry Placement Talent development programme producing PhD-level pharmaceutical scientists and engineers, combined with three-month industry placements at host sites such as Clarochem Ireland and Johnson & Johnson Little Island, Cork; offers PhD candidates industry-ready training and gives partners access to skilled researchers.

Quantifiable outcome

• 63% of SSPC graduates go on to be employed in industry both nationally and globally
• +4 more outcomes

Named customers10 records

Segments3 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability4 records

Feature7 records

Partnerships

16 partnerships are on record, tiered core, major and flagship.

• University of LimerickcoreStrategic or Co-development PartnerUniversity of Limerick hosts the SSPC headquarters at the Bernal Institute. The centre utilises UL facilities for research across all themes including manufacturing, modelling, and biopharmaceutical research.
• University College DublincoreStrategic or Co-development PartnerUCD is a co-host university for SSPC with expertise in biologics, mechanistic modelling, and asymmetric synthesis research.
• Trinity College DublincoreStrategic or Co-development PartnerTCD contributes expertise in drug delivery, enzyme-responsive polymer platforms, tumour-selective agents, and pharmaceutical sciences.
• Dublin City UniversitycoreStrategic or Co-development PartnerDCU collaborates on artificial metallo-nuclease research, CBD formulation studies, and cancer research through the Kellett group.
• Maynooth UniversitycoreStrategic or Co-development PartnerMaynooth University partners on antimicrobial peptide research, supramolecular chemistry, and peptide-based drug delivery systems.
• National Institute for Bioprocessing Research & Training (NIBRT)majorStrategic or Co-development PartnerNIBRT collaborates on mRNA stability research and biopharmaceutical training programmes.
• PfizercoreStrategic or Co-development PartnerCollaborative research on continuous anti-solvent cavi-crystallisation for design, optimisation and scale-up of continuous crystallisers.
• Johnson & Johnson Innovative MedicinecoreStrategic or Co-development PartnerIndustry placement host site at Little Island, Cork for manufacturing bulk active pharmaceutical ingredients; collaborative mRNA stability research.
• Eli Lilly and CompanycoreStrategic or Co-development PartnerCollaborative research on alternate catalyst projects for yield improvement; Dr Sarah O'Keeffe is a notable Irish leader at Lilly.
• RegeneronmajorStrategic or Co-development PartnerCollaborative PhD research on computational fluid dynamic modelling of CHO cell growth and productivity in bioreactors.
• AbbViemajorStrategic or Co-development PartnerResearch collaboration on continuous anti-solvent crystallisation in crystallisers without moving parts.
• Clarochem IrelandmajorStrategic or Co-development PartnerIndustry partner for API manufacturing and process development; hosts SSPC industry placement students.
• AlkermesmajorStrategic or Co-development PartnerCollaborative research on detection and quantification of polymorphs of drug substances in Athlone facility.
• ArrayPatch LtdflagshipStrategic or Co-development PartnerSSPC spinout company from University College Cork developing microneedle-based therapeutics. Raised €3M seed funding including participation from Enterprise Ireland and Lakeside Capital.
• Scale-up Systems (Mettler Toledo)majorStrategic or Co-development PartnerDeveloper of Dynochem and Scale-up Suite process modelling software; contributes CFD expertise and industry placement opportunities.
• International Research PartnersmajorStrategic or Co-development PartnerInternational collaborations including Chimie ParisTech (France), Chalmers University of Technology (Sweden), Sahlgrenska University Hospital (Sweden) on anticancer drug development research.

Scale indicators8 records

Recent moves6 records

Expansion highlights5 records

Others

• Amber (SFI Centre for Advanced Materials and BioEngineering Research): Adjacent Ireland-based Research Ireland-funded centre with overlap on advanced materials and bioprocessing themes. Ecosystem peer — same national funding architecture and similar structure to SSPC — rather than a direct competitor.

Direct peers

• C-SOPS (Center for Structured Organic Particulate Systems): US NSF engineering research centre at Rutgers focused on pharmaceutical solids, continuous manufacturing, and QbD-enabled drug product design; comparable in mission, funding structure (public centre-of-excellence), and core R&D themes to SSPC.
• APC Ltd (APC Process Engineering): Irish-headquartered pharma process R&D company spun out of UCD (a SSPC co-host university) — founded by SSPC figures Brian Glennon and Mark Barrett — operating in process modelling, crystallisation, and biopharma process development that maps directly onto SSPC's capabilities.
• CMAC (Continuous Manufacturing & Advanced Crystallisation): UK EPSRC Future Manufacturing Research Hub hosted at the University of Strathclyde, focused on continuous manufacturing, crystallisation, and pharmaceutical process R&D — directly overlapping SSPC's flow chemistry, continuous crystallisation, and process modelling themes.
• RCPE (Research Center for Pharmaceutical Engineering): Austrian public-private pharmaceutical engineering research centre focused on pharmaceutical process and formulation R&D, including continuous manufacturing and modelling — closely aligned with SSPC's manufacturing and modelling themes.
• NIBRT (National Institute for Bioprocessing Research & Training): Ireland-based bioprocessing research and training institute; explicitly named as an SSPC collaboration partner on mRNA stability and biopharma training. Highly comparable: same geography, same pharma R&D mission, complementary bioprocessing focus.

Broad incumbents

• The Janssen R&D Discovery and Pharmaceutical Development organisation: In-house pharma R&D of a major SSPC industry partner; represents the large internal capability set against which SSPC competes for outsourced collaborative research budgets and which it complements through joint projects.
• Lilly Research Laboratories: Major SSPC industry partner with significant in-house continuous-manufacturing and synthetic chemistry capability (e.g., Kinsale, Ireland). Important as both a buyer of SSPC research and as a benchmark for internal capability SSPC partners with.

Emerging players

• CatSci Ltd: Welsh-based specialist CRO in pharmaceutical process R&D, asymmetric synthesis, and crystallisation. Smaller and commercially focused compared with SSPC, but operates in the same niche of applied pharma process chemistry.

Regional players

• APC Microbiome Ireland: Another Research Ireland-funded centre hosted in Ireland (UCC) covering microbiome and pharma-adjacent life sciences R&D. Comparable as a public Irish research centre with industry co-funding, though different scientific focus.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

• Xx.com/SSPCentre
• YouTubeyoutube.com/channel/UCOqr_wkdgg87IctVO7NWGtQ?view_as=subscriber
• LinkedInlinkedin.com/company/sspc-the-sfi-research-centre-for-pharmaceuticals
• Instagraminstagram.com/sspcentre
• Facebookfacebook.com/sspcentre

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about SSPC